enGene Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENGN and other ETFs, options, and stocks.About ENGN
enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
ENGN Key Statistics
Stock Snapshot
With a market cap of 121.27M, enGene Therapeutics Inc.(ENGN) trades at $1.80. The stock has a price-to-earnings ratio of -0.83.
On 2026-08-06, enGene Therapeutics Inc.(ENGN) stock traded between a low of $1.76 and a high of $1.81. Shares are currently priced at $1.80, which is +2.3% above the low and -0.6% below the high.
The enGene Therapeutics Inc.(ENGN)'s current trading volume is 156.07K, compared to an average daily volume of 647.93K.
During the past year, enGene Therapeutics Inc.(ENGN) stock moved between $1.40 at its lowest and $12.25 at its peak.
During the past year, enGene Therapeutics Inc.(ENGN) stock moved between $1.40 at its lowest and $12.25 at its peak.
Analyst ratings
55%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.